IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Karyopharm Therapeutics Inc (KPTIEUR)

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Birchview Capital, LP
DECREASED
Shares42,952 from 83,952
Change-41,000 (-49%)
Value$419.6K (-$48.0K)
Filed 2026-08-14
Status
Birchview Capital, LP
DECREASED42,95283,952-41,000-49%$467.6K$419.6K-$48.0K2026-08-14
Showing 1 of 1 institutions